1. Product Overview
2. Research Methodology
3. Clinical Trial Analysis
4. Executive Summary
5. Global Neoantigen Cancer Vaccine Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value &
Volume
5.2.
Market Share & Forecast
5.2.1. By Product
(Personalized Neo-antigen Vaccine, Off-the Shelf Neoantigen Vaccine)
5.2.2. By Neoantigen Type (Synthetic
Long Peptide (SLP), Dendritic Cell, Nucleic Acid, Tumor Cell)
5.2.3. By Route of
Administration (Intravenous, Intramuscular, Transdermal, Others)
5.2.4. By Cell (Autologous,
Allogenic)
5.2.5. By Technology (RNA
Sequencing, Whole Genome Sequencing, HLA Typing)
5.2.6. By Delivery
Mechanism (Liposomes, Virosomes, Electroporation, Gene gun and Others)
5.2.7. By Application (Lung,
Melanoma, Gastrointestinal, Brain cancer, and Others)
5.2.8. By Company (2023)
5.2.9.
By Region
5.3.
Product Market Map
6. North America
Neoantigen Cancer Vaccine Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value &
Volume
6.2.
Market Share & Forecast
6.2.1. By Product
6.2.2. By Neoantigen Type
6.2.3. By Route of
Administration
6.2.4. By Cell
6.2.5. By Technology
6.2.6. By Application
6.2.7. By Country
6.3.
Product Market Map
6.4.
North America: Country Analysis
6.4.1. United States
Neoantigen Cancer Vaccine Market Outlook
6.4.1.1.
Market Size & Forecast
6.4.1.1.1.
By Value
6.4.1.2.
Market Share & Forecast
6.4.1.2.1.
By Product
6.4.1.2.2.
By Neoantigen Type
6.4.1.2.3.
By Route of Administration
6.4.1.2.4.
By Cell
6.4.1.2.5.
By Technology
6.4.1.2.6.
By Application
6.4.2. Canada Neoantigen
Cancer Vaccine Market Outlook
6.4.2.1.
Market Size & Forecast
6.4.2.1.1.
By Value
6.4.2.2.
Market Share & Forecast
6.4.2.2.1.
By Product
6.4.2.2.2.
By Neoantigen Type
6.4.2.2.3.
By Route of Administration
6.4.2.2.4.
By Cell
6.4.2.2.5.
By Technology
6.4.2.2.6.
By Application
6.4.3. Mexico Neoantigen
Cancer Vaccine Market Outlook
6.4.3.1.
Market Size & Forecast
6.4.3.1.1.
By Value
6.4.3.2.
Market Share & Forecast
6.4.3.2.1.
By Product
6.4.3.2.2.
By Neoantigen Type
6.4.3.2.3.
By Route of Administration
6.4.3.2.4.
By Cell
6.4.3.2.5.
By Technology
6.4.3.2.6.
By Application
7. Europe Neoantigen
Cancer Vaccine Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value &
Volume
7.2.
Market Share & Forecast
7.2.1. By Product
7.2.2. By Neoantigen Type
7.2.3. By Route of
Administration
7.2.4. By Cell
7.2.5. By Technology
7.2.6. By Application
7.2.7. By Country
7.3.
Product Market Map
7.4.
Europe: Country Analysis
7.4.1. Germany Neoantigen
Cancer Vaccine Market Outlook
7.4.1.1.
Market Size & Forecast
7.4.1.1.1.
By Value
7.4.1.2.
Market Share & Forecast
7.4.1.2.1.
By Product
7.4.1.2.2.
By Neoantigen Type
7.4.1.2.3.
By Route of Administration
7.4.1.2.4.
By Cell
7.4.1.2.5.
By Technology
7.4.1.2.6.
By Application
7.4.2. France Neoantigen
Cancer Vaccine Market Outlook
7.4.2.1.
Market Size & Forecast
7.4.2.1.1.
By Value
7.4.2.2.
Market Share & Forecast
7.4.2.2.1.
By Product
7.4.2.2.2.
By Neoantigen Type
7.4.2.2.3.
By Route of Administration
7.4.2.2.4.
By Cell
7.4.2.2.5.
By Technology
7.4.2.2.6.
By Application
7.4.3. United Kingdom
Neoantigen Cancer Vaccine Market Outlook
7.4.3.1.
Market Size & Forecast
7.4.3.1.1.
By Value
7.4.3.2.
Market Share & Forecast
7.4.3.2.1.
By Product
7.4.3.2.2.
By Neoantigen Type
7.4.3.2.3.
By Route of Administration
7.4.3.2.4.
By Cell
7.4.3.2.5.
By Technology
7.4.3.2.6.
By Application
7.4.4. Italy Neoantigen
Cancer Vaccine Market Outlook
7.4.4.1.
Market Size & Forecast
7.4.4.1.1.
By Value
7.4.4.2.
Market Share & Forecast
7.4.4.2.1.
By Product
7.4.4.2.2.
By Neoantigen Type
7.4.4.2.3.
By Route of Administration
7.4.4.2.4.
By Cell
7.4.4.2.5.
By Technology
7.4.4.2.6.
By Application
7.4.5. Spain Neoantigen
Cancer Vaccine Market Outlook
7.4.5.1.
Market Size & Forecast
7.4.5.1.1.
By Value
7.4.5.2.
Market Share & Forecast
7.4.5.2.1.
By Product
7.4.5.2.2.
By Neoantigen Type
7.4.5.2.3.
By Route of Administration
7.4.5.2.4.
By Cell
7.4.5.2.5.
By Technology
7.4.5.2.6.
By Application
8. Asia-Pacific
Neoantigen Cancer Vaccine Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value &
Volume
8.2.
Market Share & Forecast
8.2.1. By Product
8.2.2. By Neoantigen Type
8.2.3. By Route of
Administration
8.2.4. By Cell
8.2.5. By Technology
8.2.6. By Application
8.2.7. By Country
8.3.
Product Market Map
8.4.
Asia-Pacific: Country Analysis
8.4.1. China Neoantigen
Cancer Vaccine Market Outlook
8.4.1.1.
Market Size & Forecast
8.4.1.1.1.
By Value
8.4.1.2.
Market Share & Forecast
8.4.1.2.1.
By Product
8.4.1.2.2.
By Neoantigen Type
8.4.1.2.3.
By Route of Administration
8.4.1.2.4.
By Cell
8.4.1.2.5.
By Technology
8.4.1.2.6.
By Application
8.4.2. India Neoantigen
Cancer Vaccine Market Outlook
8.4.2.1.
Market Size & Forecast
8.4.2.1.1.
By Value
8.4.2.2.
Market Share & Forecast
8.4.2.2.1.
By Product
8.4.2.2.2.
By Neoantigen Type
8.4.2.2.3.
By Route of Administration
8.4.2.2.4.
By Cell
8.4.2.2.5.
By Technology
8.4.2.2.6.
By Application
8.4.3. Japan Neoantigen
Cancer Vaccine Market Outlook
8.4.3.1.
Market Size & Forecast
8.4.3.1.1.
By Value
8.4.3.2.
Market Share & Forecast
8.4.3.2.1.
By Product
8.4.3.2.2.
By Neoantigen Type
8.4.3.2.3.
By Route of Administration
8.4.3.2.4.
By Cell
8.4.3.2.5.
By Technology
8.4.3.2.6.
By Application
8.4.4. Australia Neoantigen
Cancer Vaccine Market Outlook
8.4.4.1.
Market Size & Forecast
8.4.4.1.1.
By Value
8.4.4.2.
Market Share & Forecast
8.4.4.2.1.
By Product
8.4.4.2.2.
By Neoantigen Type
8.4.4.2.3.
By Route of Administration
8.4.4.2.4.
By Cell
8.4.4.2.5.
By Technology
8.4.4.2.6.
By Application
8.4.5. South Korea
Neoantigen Cancer Vaccine Market Outlook
8.4.5.1.
Market Size & Forecast
8.4.5.1.1.
By Value
8.4.5.2.
Market Share & Forecast
8.4.5.2.1.
By Product
8.4.5.2.2.
By Neoantigen Type
8.4.5.2.3.
By Route of Administration
8.4.5.2.4.
By Cell
8.4.5.2.5.
By Technology
8.4.5.2.6.
By Application
8.4.6. Singapore Neoantigen
Cancer Vaccine Market Outlook
8.4.6.1.
Market Size & Forecast
8.4.6.1.1.
By Value
8.4.6.2.
Market Share & Forecast
8.4.6.2.1.
By Product
8.4.6.2.2.
By Neoantigen Type
8.4.6.2.3.
By Route of Administration
8.4.6.2.4.
By Cell
8.4.6.2.5.
By Technology
8.4.6.2.6.
By Application
9. South America
Neoantigen Cancer Vaccine Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value &
Volume
9.2.
Market Share & Forecast
9.2.1. By Product
9.2.2. By Neoantigen Type
9.2.3. By Route of
Administration
9.2.4. By Cell
9.2.5. By Technology
9.2.6. By Application
9.2.7. By Country
9.3.
Product Market Map
9.4.
South America: Country Analysis
9.4.1. Brazil Neoantigen
Cancer Vaccine Market Outlook
9.4.1.1.
Market Size & Forecast
9.4.1.1.1.
By Value
9.4.1.2.
Market Share & Forecast
9.4.1.2.1.
By Product
9.4.1.2.2.
By Neoantigen Type
9.4.1.2.3.
By Route of Administratio